Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium ulcerans | flavin-containing monoamine oxidase AofH | 0.325193 | 1 | 1 |
Mycobacterium ulcerans | beta-ketoacyl synthase-like protein | 0.0936508 | 0.277999 | 0.234045 |
Mycobacterium ulcerans | 3-oxoacyl-ACP synthase | 0.0936508 | 0.277999 | 0.234045 |
Echinococcus granulosus | lysine specific histone demethylase 1A | 0.0229009 | 0.0573844 | 1 |
Plasmodium falciparum | beta-ketoacyl-ACP synthase III | 0.0936508 | 0.277999 | 1 |
Echinococcus multilocularis | insulin growth factor 1 receptor beta | 0.0046437 | 0.000454217 | 0.00791535 |
Echinococcus granulosus | epidermal growth factor receptor | 0.00780801 | 0.0103213 | 0.173319 |
Leishmania major | UDP-galactopyranose mutase | 0.0229009 | 0.0573844 | 0.5 |
Mycobacterium tuberculosis | Probable flavin-containing monoamine oxidase AofH (amine oxidase) (MAO) | 0.302292 | 0.92859 | 1 |
Onchocerca volvulus | 0.0229009 | 0.0573844 | 0.5 | |
Echinococcus multilocularis | epidermal growth factor receptor | 0.0145322 | 0.0312888 | 0.54525 |
Schistosoma mansoni | tyrosine kinase | 0.00772563 | 0.0100644 | 0.168807 |
Echinococcus multilocularis | amiloride sensitive amine oxidase | 0.00807357 | 0.0111493 | 0.194292 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0121624 | 0.0238994 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | 3-oxoacyl-ACP synthase | 0.0936508 | 0.277999 | 0.5 |
Loa Loa (eye worm) | TK/EGFR protein kinase | 0.0145322 | 0.0312888 | 0.541621 |
Loa Loa (eye worm) | hypothetical protein | 0.0229009 | 0.0573844 | 1 |
Mycobacterium ulcerans | 3-oxoacyl-ACP synthase | 0.0936508 | 0.277999 | 0.234045 |
Schistosoma mansoni | Protoporphyrinogen oxidase chloroplast/mitochondrial precursor | 0.0229009 | 0.0573844 | 1 |
Toxoplasma gondii | histone lysine-specific demethylase | 0.0229009 | 0.0573844 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0229009 | 0.0573844 | 1 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0121624 | 0.0238994 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0229009 | 0.0573844 | 1 |
Schistosoma mansoni | copper/topaquinone oxidase | 0.00807357 | 0.0111493 | 0.187864 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0121624 | 0.0238994 | 0.5 |
Brugia malayi | Furin-like cysteine rich region family protein | 0.0145322 | 0.0312888 | 0.541621 |
Mycobacterium tuberculosis | 3-oxoacyl-[acyl-carrier-protein] synthase III FabH (beta-ketoacyl-ACP synthase III) (KAS III) | 0.0936508 | 0.277999 | 0.253229 |
Schistosoma mansoni | tyrosine kinase | 0.00772563 | 0.0100644 | 0.168807 |
Schistosoma mansoni | tyrosine kinase | 0.00780801 | 0.0103213 | 0.173319 |
Brugia malayi | amine oxidase, flavin-containing family protein | 0.0229009 | 0.0573844 | 1 |
Chlamydia trachomatis | oxoacyl-ACP synthase III | 0.0936508 | 0.277999 | 1 |
Schistosoma mansoni | tyrosine kinase | 0.00772563 | 0.0100644 | 0.168807 |
Echinococcus granulosus | amiloride sensitive amine oxidase | 0.00807357 | 0.0111493 | 0.187864 |
Loa Loa (eye worm) | hypothetical protein | 0.0229009 | 0.0573844 | 1 |
Echinococcus granulosus | epidermal growth factor receptor | 0.0145322 | 0.0312888 | 0.541621 |
Brugia malayi | hypothetical protein | 0.0229009 | 0.0573844 | 1 |
Trypanosoma cruzi | UDP-galactopyranose mutase | 0.0229009 | 0.0573844 | 0.5 |
Schistosoma mansoni | amine oxidase | 0.0229009 | 0.0573844 | 1 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0121624 | 0.0238994 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0229009 | 0.0573844 | 1 |
Echinococcus multilocularis | epidermal growth factor receptor | 0.00780801 | 0.0103213 | 0.179862 |
Schistosoma mansoni | tyrosine kinase | 0.00780801 | 0.0103213 | 0.173319 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0121624 | 0.0238994 | 0.5 |
Echinococcus multilocularis | 0.0229009 | 0.0573844 | 1 | |
Trypanosoma cruzi | UDP-galactopyranose mutase | 0.0229009 | 0.0573844 | 0.5 |
Echinococcus granulosus | lysine specific histone demethylase 1A | 0.0229009 | 0.0573844 | 1 |
Plasmodium vivax | beta-ketoacyl-acyl carrier protein synthase III precursor, putative | 0.0936508 | 0.277999 | 1 |
Echinococcus multilocularis | insulin receptor | 0.0046437 | 0.000454217 | 0.00791535 |
Schistosoma mansoni | tyrosine kinase | 0.0145322 | 0.0312888 | 0.541621 |
Echinococcus multilocularis | protoporphyrinogen oxidase | 0.0229009 | 0.0573844 | 1 |
Echinococcus granulosus | melanoma receptor tyrosine protein kinase | 0.00780801 | 0.0103213 | 0.173319 |
Schistosoma mansoni | amine oxidase | 0.0229009 | 0.0573844 | 1 |
Echinococcus multilocularis | lysine specific histone demethylase 1A | 0.0229009 | 0.0573844 | 1 |
Mycobacterium ulcerans | flavin-containing monoamine oxidase AofH | 0.325193 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.00807357 | 0.0111493 | 0.187864 |
Mycobacterium leprae | PROBABLE PROTOPORPHYRINOGEN OXIDASE HEMY (PROTOPORPHYRINOGEN-IX OXIDASE) (PROTOPORPHYRINOGENASE) (PPO) | 0.0229009 | 0.0573844 | 0.5 |
Schistosoma mansoni | Lysine-specific histone demethylase 1 | 0.0229009 | 0.0573844 | 1 |
Brugia malayi | SWIRM domain containing protein | 0.0229009 | 0.0573844 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0229009 | 0.0573844 | 1 |
Toxoplasma gondii | histone lysine-specific demethylase LSD1/BHC110/KDMA1A | 0.0229009 | 0.0573844 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = 5.4 nM | Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7 infected type A+ human erythrocytes after 24 hrs by [G-3H]hypoxanthine uptake | ChEMBL. | 19251414 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 | 19251414 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.